AR and cholangiocarcinoma: In terms of AR specifically in biliary tract cancer, structural variants have been associated with a risk of gallbladder cancer, and AR signaling has been implicated in hepatocellular cancer development although there has not been a direct link with cholangiocarcinoma [46, 47].